# A Study of FB1003 in Healthy and Osteoarthritis Pain Subjects

> **NCT06343714** · PHASE1 · RECRUITING · sponsor: **4B Technologies Limited** · enrollment: 64 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** FB1003
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06343714
- **Lead sponsor:** 4B Technologies Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-07
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-05-30
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06343714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06343714, "A Study of FB1003 in Healthy and Osteoarthritis Pain Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06343714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*